Akanda Corp. (AKAN) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Akanda Corp. (AKAN:NASDAQ), powered by AI.

Current Price
$10.21
P/E Ratio
-2.6
Market Cap
11M
Sector
Healthcare
What is the Akanda Corp. stock price forecast?

Akanda Corp. is currently trading at $10.21. View real-time AI analysis on Alpha Lenz.

What is Akanda Corp. insider trading activity?

View the latest insider trading data for Akanda Corp. on Alpha Lenz.

What is Akanda Corp.'s P/E ratio?

Akanda Corp.'s P/E ratio is -2.6.

Akanda Corp.

NASDAQ · AKAN
$10.21
Ask about Akanda Corp.'s future dividend policy...
Alpha Chat Insight

Akanda Corp. trades at a P/E of -2.6 (undervalued) with modest ROE of -1830.0%. 3Y revenue CAGR of 172.3% highlights clear growth momentum.

Ask for details

Company Overview

Akanda Corp. is an equity security representing a company that operates in industries related to medical cannabis and wellness solutions. The primary function of Akanda Corp. is to develop, cultivate, process, and distribute cannabis-derived products aimed at both medicinal and therapeutic applications. The company’s offerings typically span a range of cannabis-based products designed to serve the healthcare sector, targeting patients and medical professionals who require regulated and reliable alternatives for treatment. As a newly listed entity in August 2025, Akanda Corp. highlights the ongoing international integration of the cannabis sector into regulated financial markets, reflecting both evolving consumer demand and shifting legal frameworks worldwide. The company's presence adds diversity to the financial market, offering investors exposure to the intersection of healthcare innovation and agricultural technology. By participating in the capital markets, Akanda Corp. supports advancements in cannabis research, promotes product quality standards, and may contribute to shaping regulatory best practices across the global wellness industry.

CEOMs. Katharyn Field
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees46

Company Statistics

FY 2024

Profile

$10.64MMarket Cap
$836.66KRevenue
0.00Shares Out
46Employees

Margins

24.91%Gross
-477.66%EBITDA
-523.80%Operating
-390.65%Pre-Tax
-489.57%Net

Valuation

-2.60P/E
2.49P/B
12.72EV/Sales
-1.79EV/EBITDA
-1.75P/FCF

Growth (CAGR)

172.32%Rev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-48.90%ROA
-1830.03%ROE
-37.82%ROIC

Financial Health

$3.84MCash & Cash Equivalents
$-201.10KNet Debt
85.06%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Akanda Corp. (ticker: AKAN) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 46 employees. Market cap is $11M.

The current price is $10.21 with a P/E ratio of -2.6x and P/B of 2.49x.

ROE is -1830.03% and operating margin is -523.80%. Annual revenue is $836,664.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Akanda Corp. (Healthcare) Stock Forecast & Analysis $10.21 | Alpha Lenz